Toggle navigation
Home
Search
Services
Blog
Contact
About
Preclinical Evaluation of Intermediate Endpoints and
Clapper, Margie
Fox Chase Cancer Center, Philadelphia, PA, United States
Search 57 grants from Margie Clapper
Search grants from Fox Chase Cancer Center
Share this grant:
:
:
Abstract
Funding
Institution
Related projects
Comments
Recent in Grantomics:
Your institution
vs. funders. Who wins?
Read more...
How should you pick the next fundable research topic?
Read more...
Recently viewed grants:
LncRNA with MSI2 and super-enhancer in liver cancer stem cells induced by alcohol
Epigenetic Changes in the Glucocorticoid Receptor Gene Due to Arsenic Exposure
Tsetse Fecundity Reduction for Trypanosomiasis Control
Core - Research Pharmacy
C2-Symmetric Macrocyclic Dimer Synthesis
Recently added grants:
Multivalent DNA vaccine-mediated protection against Tuberculosis
Host Genes Critical for Flavivirus Infection
The integrated stress response in stem cells and cancer
ST8Sia6 expression on tumors inhibits the immune response
A-Z Clinical Trials Unit
Abstract
Funding Agency
Agency
National Institute of Health (NIH)
Institute
Division of Cancer Prevention And Control (NCI)
Type
Research and Development Contracts (N01)
Project #
N01CN025496-001001
Application #
3617866
Study Section
Project Start
1992-09-30
Project End
Budget Start
1993-06-17
Budget End
1994-09-30
Support Year
Fiscal Year
1993
Total Cost
Indirect Cost
Institution
Name
Fox Chase Cancer Center
Department
Type
DUNS #
042250712
City
Philadelphia
State
PA
Country
United States
Zip Code
19111
Related projects
NIH 1993
N01 CN
Preclinical Evaluation of Intermediate Endpoints and
Clapper, Margie / Fox Chase Cancer Center
NIH 1992
N01 CN
Preclinical Evaluation of Intermediate Endpoints and
Clapper, Margie / Fox Chase Cancer Center
Comments
Be the first to comment on Margie Clapper's grant